Theophylline/ephedra/hydroxyzine

Theophylline/ephedra/hydroxyzine
Combination of
TheophyllineStimulant
Ephedra (medicine)Stimulant
HydroxyzineAntihistamine
Clinical data
Trade namesMarax
AHFS/Drugs.comMicromedex Detailed Consumer Information
Routes of
administration
By mouth
ATC code
Identifiers
CAS Number
PubChem SID

Theophylline/ephedra/hydroxyzine (trade name Marax) is a drug that was used for the treatment of asthma. It was a combination of theophylline, ephedra,[1] and hydroxyzine, and taken by mouth.[2][3] It is no longer manufactured in the US due to approval of ephedra being withdrawn by the FDA.[citation needed]

  1. ^ Hunt TM (2011). Drug Games: The International Olympic Committee and the Politics of Doping, 1960–2008. University of Texas Press. p. 45. ISBN 978-0-292-73957-4. Retrieved 20 July 2018.
  2. ^ Marax Micromedex Detailed Consumer Information. Accessed 23 April 2021.
  3. ^ Fixley M, Shen DD, Azarnoff DL (June 1977). "Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline". The American Review of Respiratory Disease. 115 (6): 955–62. doi:10.1164/arrd.1977.115.6.955 (inactive 1 November 2024). PMID 262107.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)